60 Degrees Pharmaceuticals Inc
SXTP
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.4M
Close$
$-3.01
451.4% downside
Current Fair Value
451.4% downsideOvervalued by 451.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.40 Million |
|---|---|
| Enterprise Value | $2.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.73 |
| Beta | 2.4 |
| Outstanding Shares | 2,653,848 |
Return
| Return on Equity | -320.90% |
|---|---|
| Return on Assets | -189.46% |
| Return on Invested Capital | -318.47% |
Valuation & Multiples
| P/E Ratio | -0.16 |
|---|---|
| PEG | -0.5 |
| Price to Sales | - |
| Price to Book Ratio | 0.86 |
| Enterprise Value to Revenue | 2.14 |
| Enterprise Value to EBIT | -0.28 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$445,000
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.61
Average shareholder expectationRevenue Estimate
$270,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.16%▲ 1.90% |
|---|---|
| Total Invested | $614,803▲ 80.79% |
| Investors Holding | 80% |
ESG Score
No data